No abstract

No abstract

Currently, the ketogenic diet (KD) is used to treat obesity. A prospective study on the use of KD and nutraceutical correction of the nutritional status of patients with lipedema was carried out. Aim. To study the effect of the ketogenic diet, accompanied by correction of changes in the intestinal microbiome and hepatoprotection,on the reduction of fatty deposits in lipedema and the dynamics of changes in lipid and carbohydrate metabolism hormones. Material and methods. 60 patients with lower limb lipedema of stages I-III were randomized into 2 groups: Group 1 received a lowcalorie diet (LCD), physical exercises in the gym (PE), and physical activity (FA) in the form of daily walking up to 3-5 km/ day. Group 2 received a modified version of the Atkins ketogenic diet, physical exercises in the gym and FA, as well as nutraceutical correction of increased appetite, probiotic intestinal composition, hepatoprotection. The duration of the treatment course was 4 weeks. Anthropometric methods and bioimpedansometry were used to control limb circumferences, waist and thigh. Results and discussion. After treatment, patients in 1st group showed a decrease in body weight, lean and active cell mass, a decrease in musculoskeletal mass, and a decrease in total water due to extracellular water. A decrease in total cholesterol and high density lipoproteins (HDL) fraction, an increase in blood triglyceride fraction was noted. Leptin decreased by 12.73%. Patients of the 2nd group showed a decrease in body weight, fat mass, lean mass, total water and extracellular water. There was a decrease in total cholesterol, triglycerides, transaminases. Leptin decreased by 32.02%, insulin decreased by 9.87%. To prevent the development of fatty hepatosis against the background of the use of KD, patients of the 2nd group received nutraceutical correction: hepatoprotector Gepamin, metaprebiotic Stimbifid-plus, modulating the formation of resident intestinal microbiota. To reduce appetite, the patients of the 2nd group were also prescribed anorexic - an algal product Nativ containing the polysaccharide fucoidan, having a prebiotic effect. Improvement of reparative processes in the liver, suppression of oxidative processes also contributed to the restoration of the sensitivity of insulin receptors, which was confirmed by the normalization of the lipid-carbohydrate spectrum of blood in patients of the 2nd group after the course of the treatment. The insulin decrease in patients of Group 2 indicated not only insulin resistance decrease , but also the lipogenesis decrease and stimulation of lipolysis. Adipose tissue reduction due to lipolysis stimulation was also indicated by a decrease in leptin expression. Conclusion. Thus, a ketogenic diet, accompanied by nutraceutical correction of the intestinal microbiome and hepatoprotection can be effectively used in combination with physical activity in order to reduce body weight, fat mass and edema, as evidenced by a decrease in the expression level of leptin and insulin, correlating with the levels of fat loss and free water.

The paper reflects the leading causes of the development and prevalence of arterial hypertension in the population, shows the ways of alimentary correction of nutritional status disorders in patients with arterial hypertension, substantiates the possibility and effectiveness of using specialized meat products in the nutrition of patients with arterial hypertension.

Совершенствование наружной и системной терапии они хомикозов сталкивается с проблемами оценки эффектив ности лечения в отдаленные сроки, рецидивов и реин фекций после окончания терапии. Это может приводить к разночтениям в сравнении современных схем лечения онихомикозов, существенному разбросу данных по эф фективности через несколько лет наблюдения (20 60%). Проведен мета анализ результатов международных иссле дований, оценивающих отдаленные результаты терапии, причины неэффективного лечения и возможные спосо бы их устранения. Представлены данные собственного 4 летнего исследования отдаленной эффективности лече ния онихомикозов, новые сведения о сравнительной эф фективности препаратов аллиламинов (включая 1% на фтифин), азолов и других групп, показаны преимущества аллиламиновых соединений в наружной и системной те рапии онихомикозов. Даны рекомендации по клинико микологическому контролю излеченности при онихоми козе, личной и общественной профилактике реинфици рования.